Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
PROGNOSIS AND THERAPY OF SECONDARY MYELODYSPLASTIC SYNDROMES
Autore:
ESTEY EH;
Indirizzi:
UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT LEUKEMIA,BOX 61,1515 HOLCOMBE BLVD HOUSTON TX 77030
Titolo Testata:
Haematologica
fascicolo: 6, volume: 83, anno: 1998,
pagine: 543 - 549
SICI:
0390-6078(1998)83:6<543:PATOSM>2.0.ZU;2-6
Fonte:
ISI
Lingua:
ENG
Soggetto:
ALLOGENEIC MARROW TRANSPLANTATION; DOSE CYTOSINE-ARABINOSIDE; SCORING SYSTEM; FAB CLASSIFICATION; LONG-TERM; LEUKEMIA; ANEMIA; CHEMOTHERAPY; DESFERRIOXAMINE; DISEASE;
Keywords:
INTERNATIONAL PROGNOSTIC SCORING SYSTEM; ERYTHROPOIETIN; G-CSF; AML-TYPE CHEMOTHERAPY; TOPOTECAN; ALLOGENEIC TRANSPLANT;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
41
Recensione:
Indirizzi per estratti:
Citazione:
E.H. Estey, "PROGNOSIS AND THERAPY OF SECONDARY MYELODYSPLASTIC SYNDROMES", Haematologica, 83(6), 1998, pp. 543-549

Abstract

This is an invited review of a condition that is likely to become increasingly frequent in coming years. The objective is to define the varying prognoses of the condition and to discuss treatment options for patients with better and worse prognoses. The source of the data is theliterature. Of particular note are the paper by Greenberg et al. describing the International Prognostic Scoring System for MDS and that byEstey et al. describing the similar response of AML, RAEB-t, and RAEBto AML-type chemotherapy. The state of the art is that no satisfactory therapeutic options exist; consequently, the majority of patients with secondary MDS should participate in clinical trials.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 00:55:00